Jenum Synne, Selvam Sumithra, Mahelai Diana, Jesuraj Nelson, Cárdenas Vicky, Kenneth John, Hesseling Anneke C, Doherty Timothy Mark, Vaz Mario, Grewal Harleen M S
From the *Center for Immune Regulation, Oslo University Hospital, Rikshospitalet-Radiumhospitalet Medical Center and the University of Oslo, Oslo, Norway; †Division of Epidemiology, Biostatistics and Population Health; ‡Division of Infectious Diseases, St. John's Research Institute, Bangalore, India; §Aeras, Rockville, MD; ¶Department of Paediatrics and Child Health, Desmond Tutu TB Center, Stellenbosch University, Cape Town, South Africa; ‖GlaxoSmithKline Pharma, Vaccines, Copenhagen, Denmark; **Division of Health and Humanities, St. John's Research Institute, Bangalore, India; and ††Department of Clinical Science, University of Bergen and Department of Microbiology, Haukeland University Hospital, Bergen, Norway.
Pediatr Infect Dis J. 2014 Oct;33(10):e260-9. doi: 10.1097/INF.0000000000000399.
Reliable identification of Mycobacterium tuberculosis infection or tuberculosis (TB) disease in young children is vital to assure adequate preventive and curative treatment. The tuberculin skin test (TST) and IFNγ-release assays may supplement the diagnosis of pediatric TB as cases are typically bacteriologically unconfirmed. However, it is unclear to what extent the performance of TST and QuantiFERON-TB Gold In-Tube (QFT; Cellestis' IFNγ-release assay test) depends on the demographic, clinical and nutritional characteristics of children in whom they are tested.
During a 2-year prospective observational study of 4382 neonates in Southern India, children with suspected TB were investigated and classified by a standard TB diagnostic algorithm.
Clinical TB was diagnosed in 13 of 705 children referred for case verification with suspected TB. TST and QFT had a susceptibility for clinical TB of 31% and 23%, respectively, in this group. Children <2 years were more likely to test QFT indeterminate. A height-for-age Z score within the lowest quartile increased the odds ratio (OR) for a positive or indeterminate QFT result [OR 2.46 (1.19-5.06), OR 3.08 (1.10-8.58)], whereas the OR for a positive TST was reduced with a weight-for-height Z score within the lowest quartile [OR 0.17 (0.06-0.47)].
The sensitivities of the TST and QFT for clinical TB in children <3 years of age were equally poor in this population. Stunted children were more susceptible to Mycobacterium tuberculosis infection and more prone to indeterminate QFT results. TST was less reliable in children with wasting.
可靠地识别幼儿的结核分枝杆菌感染或结核病对于确保充分的预防和治疗至关重要。结核菌素皮肤试验(TST)和γ-干扰素释放试验可辅助小儿结核病的诊断,因为这些病例通常未经细菌学确诊。然而,TST和结核感染T细胞检测(QFT;Cellestis公司的γ-干扰素释放试验)的检测性能在多大程度上取决于接受检测儿童的人口统计学、临床和营养特征尚不清楚。
在印度南部对4382名新生儿进行的为期2年的前瞻性观察研究中,对疑似结核病的儿童进行调查,并按照标准的结核病诊断算法进行分类。
在705名因疑似结核病转诊进行病例核实的儿童中,有13名被诊断为临床结核病。在该组中,TST和QFT对临床结核病的敏感度分别为31%和23%。2岁以下儿童的QFT检测结果更有可能不确定。年龄别身高Z评分处于最低四分位数会增加QFT结果为阳性或不确定的比值比(OR)[OR 2.46(1.19 - 5.06),OR 3.零八(1.10 - 8.58)],而身高别体重Z评分处于最低四分位数时,TST结果为阳性的OR会降低[OR 0.17(0.06 - 0.47)]。
在该人群中,TST和QFT对3岁以下儿童临床结核病的敏感度同样较低。发育迟缓的儿童更容易感染结核分枝杆菌,且更易出现QFT结果不确定的情况。消瘦儿童的TST结果可靠性较低。